Treatments for Acute Intermittent Porphyria

 Treatments for Acute Intermittent Porphyria

Drugs used to treat Acute Intermittent Porphyria

 

givosiran

hemin

chlorpromazine

Givlaari

Panhematin

 

What is Acute Intermittent Porphyria?

 

Acute Intermittent Porphyria (AIP) is a rare genetic disorder affecting the production of heme, a component vital to hemoglobin in red blood cells. It falls under the category of hepatic porphyrias, a group of disorders where the liver is involved in the overproduction of certain chemical intermediates in heme synthesis. Heme, which is crucial for oxygen transport, enzyme function, and cell health, depends on a multi-step synthesis process. In AIP, a defect in one of these steps leads to a buildup of porphyrin precursors, causing the characteristic symptoms of the disease.

 

1. Genetics and Causes

   - Inheritance: AIP is an autosomal dominant condition, meaning only one copy of the mutated gene (inherited from either parent) can lead to the disorder. However, not everyone with the genetic mutation will experience symptoms.

   - Gene Mutation: The condition is caused by a mutation in the HMBS gene, which encodes the enzyme hydroxymethylbilane synthase. This enzyme is essential in the heme synthesis pathway. When its activity is reduced, toxic intermediates, such as porphobilinogen (PBG) and delta-aminolevulinic acid (ALA), accumulate, particularly in the liver.

 

2. Triggers and Risk Factors

   - Hormonal Changes: Many attacks occur in women, often due to hormonal fluctuations, particularly around menstruation.

   - Medications: Certain drugs (like barbiturates, anti-seizure medications, and sulfonamides) can trigger attacks.

   - Alcohol and Smoking: Both can provoke symptoms.

   - Fasting or Extreme Dieting: Low carbohydrate intake and fasting can trigger an attack.

   - Infections: Infections and physical stress may exacerbate symptoms.

 

3. Symptoms

   AIP is known for its episodic attacks, which can vary widely between individuals. Attacks may last from days to weeks and may include:

   - Abdominal Pain: Often severe, the most common symptom of AIP.

   - Neurological Symptoms: These can include numbness, tingling, muscle weakness, and, in severe cases, paralysis.

   - Psychiatric Symptoms: Anxiety, depression, and even psychosis can occur during attacks.

   - Autonomic Symptoms: Rapid heart rate, high blood pressure, and digestive issues, such as constipation or vomiting.

   - Hyponatremia: Low sodium levels, which can lead to confusion, seizures, or altered consciousness.

 

4. Diagnosis

   - Urine Tests: Measuring levels of PBG and ALA during an acute attack is critical. Elevated levels confirm the diagnosis of an acute porphyria.

   - Genetic Testing: Identifying the HMBS gene mutation helps confirm the diagnosis and can be useful for screening family members.

   - Blood and Stool Tests: These can also help distinguish between different types of porphyria.

 

5. Treatment and Management

   Treatment is primarily aimed at managing symptoms and preventing attacks:

   - Acute Attack Management:

     - Intravenous Heme: Heme arginate or hematin infusions are given to reduce the production of porphyrin precursors by providing feedback inhibition.

     - Carbohydrate Loading: High-dose glucose infusions can help by inhibiting the synthesis pathway and are sometimes effective for mild attacks.

   - Long-term Management:

     - Avoid Triggers: Patients are advised to avoid known triggers, such as certain medications and alcohol.

     - Hormonal Management: In women, hormonal therapies or suppressing ovulation may help prevent cyclical attacks.

     - Liver Transplant: In severe cases, a liver transplant may be considered as a last resort.

 

6. Complications

   - Chronic Pain: Some individuals experience ongoing pain even between acute attacks.

   - Kidney Damage: Chronic kidney disease is a possible long-term complication.

   - Liver Cancer: AIP patients have an increased risk of developing hepatocellular carcinoma.

 

7. Prognosis

   - With proper management, most individuals can lead normal lives with few attacks. However, recurrent attacks and complications can impact quality of life. Early diagnosis and education on avoiding triggers are key to preventing severe attacks.

 

8. Lifestyle and Support

   - Diet: Maintaining a balanced diet with adequate carbohydrates is crucial.

   - Medical ID: Many patients carry a medical ID to alert healthcare providers of their condition in case of emergency.

   - Patient Support: Joining support groups can be helpful, as managing AIP can be challenging both physically and emotionally.